NRx Pharmaceuticals Statistics

Total Valuation

NRXP has a market cap or net worth of $135.01 million. The enterprise value is $129.23 million.

Market Cap	135.01M
Enterprise Value	129.23M

Important Dates

The last earnings date was Friday, May 15, 2026, after market close.

Earnings Date	May 15, 2026
Ex-Dividend Date	n/a

Share Statistics

NRXP has 36.20 million shares outstanding. The number of shares has increased by 102.50% in one year.

Current Share Class	36.20M
Shares Outstanding	36.20M
Shares Change (YoY)	+102.50%
Shares Change (QoQ)	+11.62%
Owned by Insiders (%)	4.92%
Owned by Institutions (%)	13.84%
Float	30.45M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	58.88
Forward PS	3.62
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	56.36
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.29

Current Ratio	0.29
Quick Ratio	0.27
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-19.01

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-110.23%
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	129.50%
Weighted Average Cost of Capital (WACC)	16.70%
Revenue Per Employee	$79,069
Profits Per Employee	-$846,207
Employee Count	29
Asset Turnover	0.24
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +14.07% in the last 52 weeks. The beta is 2.19, so NRXP's price volatility has been higher than the market average.

Beta (5Y)	2.19
52-Week Price Change	+14.07%
50-Day Moving Average	3.48
200-Day Moving Average	2.68
Relative Strength Index (RSI)	49.45
Average Volume (20 Days)	1,443,384

Short Selling Information

The latest short interest is 5.71 million, so 15.78% of the outstanding shares have been sold short.

Short Interest	5.71M
Short Previous Month	4.98M
Short % of Shares Out	15.78%
Short % of Float	18.75%
Short Ratio (days to cover)	3.79

Income Statement

In the last 12 months, NRXP had revenue of $2.29 million and -$24.54 million in losses. Loss per share was -$0.97.

Revenue	2.29M
Gross Profit	1.16M
Operating Income	-17.19M
Pretax Income	-24.54M
Net Income	-24.54M
EBITDA	-17.06M
EBIT	-17.19M
Loss Per Share	-$0.97

Full Income Statement

Balance Sheet

The company has $6.71 million in cash and $934,000 in debt, giving a net cash position of $5.78 million or $0.16 per share.

Cash & Cash Equivalents	6.71M
Total Debt	934,000
Net Cash	5.78M
Net Cash Per Share	$0.16
Equity (Book Value)	-13.82M
Book Value Per Share	-0.41
Working Capital	-17.82M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-14.93M
Capital Expenditures	n/a
Depreciation & Amortization	132,000
Net Borrowing	5.00M
Free Cash Flow	-14.93M
FCF Per Share	-$0.41

Full Cash Flow Statement

Margins

Gross Margin	50.46%
Operating Margin	-749.63%
Pretax Margin	-1,070.21%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

NRXP does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-102.50%
Shareholder Yield	-102.50%
Earnings Yield	-18.18%
FCF Yield	-11.06%

Analyst Forecast

The average price target for NRXP is $42.00, which is 1,026.01% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$42.00
Price Target Difference	1,026.01%
Analyst Consensus	Strong Buy
Analyst Count	4
Revenue Growth Forecast (3Y)	832.19%
EPS Growth Forecast (3Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on April 2, 2024. It was a reverse split with a ratio of 1:10.

Last Split Date	Apr 2, 2024
Split Type	Reverse
Split Ratio	1:10

Scores

NRXP has an Altman Z-Score of -41.25 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-41.25
Piotroski F-Score	2